filmov
tv
advanced myeloproliferative neoplasms
0:05:59
How Will Advanced Technologies Enhance Myeloproliferative Neoplasm Care?
0:20:46
Biology and therapy of advanced systemic mastocytosis
0:24:52
Combination Therapy with JAK2 inhibitors in MPN
0:20:50
Prognosis and outcome of patients with advanced ET and PV
0:01:22
Recognizing PV That Has Become Advanced: Lindsey Lyle, MS, PA-C
0:02:43
The management of advanced phase MPNs
0:02:47
Dr Watts on the Investigation of INCB057643 in Advanced Myelofibrosis and MPN
0:02:53
AlloSCT in advanced systemic mastocytosis: who, when, and how?
0:04:00
Explaining Myeloproliferative Neoplasm Disease Progression to Patients
0:23:28
#BenchToBedside: Myeloproliferative Neoplasms
0:02:15
MARS: mutation-adjusted risk score for advanced systemic mastocytosis
1:25:59
NCCN Patient Webinar: Myeloproliferative Neoplasms (MPN)
0:04:12
How MPN Researchers Collaborate to Advance Patient Care
0:02:18
Dr. Claire Harrison on the Benefits of Ruxolitinib in Advanced Myelofibrosis
0:19:03
Assessment of novel treatment options for patients with PV
0:03:09
Are there Non-Pharmacologic Strategies for Managing Myeloproliferative Neoplasms?
0:02:21
Avapritinib updates in advanced systemic mastocytosis: EXPLORER and PIONEER
0:27:27
Biology and therapy of advanced mastocytosis
0:55:17
Living with a Myeloproliferative Neoplasm - Webinar
0:05:59
Is Technology Accelerating Progress in Myeloproliferative Neoplasm Care?
0:02:51
Empowering Patients With Advanced Polycythemia Vera (PV) Through Personalized Care
0:01:06
John Mascarenhas, MD, on the role of molecular analysis in myeloproliferative neoplasms
0:03:23
FDA approval of pemigatinib for R/R myeloid/lymphoid neoplasms: a major advance in the field
0:04:08
Prof Claire Harrison at ASH 2014 Highlights on myeloproliferative neoplasms
Вперёд
welcome to shbcf.ru